We identified a significant impact ( P < .05) of CSMD3 mutational status (supplemental Figure 3) on both overall survival and progression-free survival; upon correction for multiple testing according to the Bonferroni method, an additional effect regarding ZNF462 mutation status failed to reach statistical significance, and neither gene was significantly mutated according to the subsequent MutSigCV analysis.
← all excerpts
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
1
—
—